PARP2 and neoplasm: According to research, PARP2 inhibitors can not only inhibite the repair of tumor cell DNA damage and promote tumor cell apoptosis as a single agent, but also enhance the efficacy of radiotherapy and chemotherapy with alkylating agents and platinum drugs [17].